NCT06540235

Brief Summary

The goal of this clinical trial is to learn if the Otolith Labs device can improve vestibular function of subjects with vestibular migraine. The main questions it aims to answer are:

  • When the Otolith Labs device is on, are objective measures of the vestibular system better than when the device is off?
  • When the Otolith Labs device is on are subjective measures of the vestibular system better than when the device is off?
  • Are the objective measures related to the subjective measures? Researchers will change the order of the device settings to ensure the changes aren't due to the order they are tested. Participants will:
  • Wear the Otolith Labs device while in a rotary chair at different settings for different tests. All of the rotary chair testing will take less than an hour.
  • Answer questions about how the rotary chair testing made them feel for each test.
  • Answer questions about their every-day susceptibility to motion sickness and about their vestibular migraine symptoms.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

August 27, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

July 31, 2024

Last Update Submit

August 27, 2025

Conditions

Keywords

Vestibular MigraineCentral velocity storageVestibular conditionMigraine Associated Vertigo

Outcome Measures

Primary Outcomes (1)

  • Reduction of time constant

    Time constant of slow-phase saccade attenuation in rotary chair

    60 minutes

Secondary Outcomes (3)

  • Motion sickness symptom

    60 minutes

  • Vestibular migraine handicap

    60 minutes

  • Motion sickness experience

    60 minutes

Study Arms (3)

Off low high

EXPERIMENTAL

Device order will start with the device turned on but stimulation off, then the low setting and then the high setting

Device: Otolith Device Active

Off high low

EXPERIMENTAL

Device order will start with the device turned on but stimulation off, then the high setting and then the low setting

Device: Otolith Device Active

Off off off

PLACEBO COMPARATOR

Device will always be turned on but stimulation off to measure test-retest variability.

Device: Otolith Device Inactive

Interventions

The device will be providing different levels of stimulation hypothesized to affect the vestibular system

Off high lowOff low high

The device will be providing no stimulation to measure test-retest

Off off off

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Definite or probable vestibular migraine
  • Residing in the United States

You may not qualify if:

  • Head injury (e.g. skull fracture, concussion) within the last six months
  • Neurodegenerative disorder
  • Recent use of specified medications
  • History of:
  • Vestibular neuritis / labyrinthitis
  • Vestibular schwannoma or acoustic neuroma
  • Radiographically unexplored unilateral or sudden sensorineural hearing loss
  • History of surgery to the skull base or head,
  • Surgery to the middle ear in the past 6 months,
  • Surgery to the inner ear (e.g. labyrinthectomy) at any time.
  • Eye surgery within the previous 3 months
  • Significant reported history of ear disease, intravenous ototoxic medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dizzy and Vertigo Institute of Los Angeles

Beverly Hills, California, 90211, United States

Location

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Study Officials

  • Didier Depireux, PhD

    Otolith Labs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The device setting order is randomized to the participant.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 6, 2024

Study Start

August 27, 2024

Primary Completion

August 27, 2025

Study Completion

November 1, 2025

Last Updated

September 4, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data (IPD) available to other researchers.

Locations